The Company has completed the transaction for the disposal of 26,691,358 shares of Oneness Biotech Co., Ltd.(Supplement to the announcement on 2024/10/24)

Published: 2024-10-25

 

No	1	Date of announcement	2024/10/25	Time of announcement	08:35:14
Subject	The Company has completed the transaction for the disposal of 26,691,358 shares of Oneness Biotech Co., Ltd.(Supplement to the announcement on 2024/10/24)
Date of events	2024/10/25			To which item it meets	paragraph 20
Name of the securities:(4743) Oneness Biotech Co., Ltd. Trading date:2024/10/25 Amount, unit price, and total monetary amount of the transaction: (1) Quantity:26,691,358 common shares (Of which 7,800,000 shares are sold to Microbio Co., Ltd. The remaining 18,891,358 shares are entrusted to a third-party intermediary to negotiate withinternational institutional investors.) (2) Unit price:NT$125.85 per share (3)Total monetary amount：NT$3,359,107 thousands. Gain (or loss) through disposal (not applicable in case of acquisition of securities): Based on the acquisition cost, the realized profit was NT$2,082,505 thousands, of which NT$3,667,807 thousands in realized profit was recognized in prior years’ income and carried forward as undistributed earnings. The realized loss of NT$1,585,302 thousands was recognized in 2024 as part of the profit or loss on financial assets at fair value through profit or loss. Relationship with the underlying company of the trade: Investor’s investment is accounted for by using the equity method Current cumulative amount held, monetary amount, and shareholding percentage of cumulative holdings of the securities being traded (including the current trade), and status of any restriction of rights (e.g.pledges): Before the disposal: (1)Cumulative no. of shares held: 26,691,358 common shares (2)Cumulative monetary amount: NT$3,683,408 thousands (Calculated at the closing price on 10/24) (3)Shareholding percentage: 5.58% (4)Restriction of rights: None After the disposal: (1)Cumulative no. of shares held: 0 common share (2)Cumulative monetary amount: NT$0 (3)Shareholding percentage: 0.00% (4)Restriction of rights: None Current ratio of securities investment (including the current trade, as listed in article 3 of Regulations Governing the Acquisition and Disposal of Assets by Public Companies) to the total assets and equity attributable to owners of the parent as shown in the most recent financial statement and working capital as shown in the most recent financial statement as of the present: (1)Current ratio to the total assets: 60.03% (2)Current ratio to the equity attributable to owners of the parent: 60.89% (3)Working capital: NT$6,707,484 thousands Concrete purpose of the acquisition or disposal: The Company has made the commitment to dispose of all its shares in Oneness Biotech Co., Ltd. by December 31, 2024 when applying for listing on TWSE. This transaction is to fulfill the listing commitment and realize investment returns. Any dissenting opinions of directors to the present transaction:None. Whether the counterparty of the current transaction is a related party:Yes. Trading counterparty and its relationship with the Company: The Company is an affiliate of Microbio Co., Ltd., which investments is accounted for by using the equity method. The remaining transactions with international institutional investors are considered non-related party transactions. Date of the board of directors resolution:2024/10/24 Date of ratification by supervisors or approval by the audit committee:2024/10/24 Any other matters that need to be specified: The transaction was conducted through block trades (paired trades) during pre-market trading on 2024/10/25.